Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00024765
DRKS00024765
Completed
Not Applicable

Effects of altered microcirculation on renal function in transfemoral, transapical, and open aortic valve replacement. - MiNiAKE

Klinik für AnästhesiologieUniversitätsklinikum Heidelberg0 sites100 target enrollmentMarch 31, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsI35.8N17.2Other aortic valve disordersAcute renal failure with medullary necrosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I35.8
Sponsor
Klinik für AnästhesiologieUniversitätsklinikum Heidelberg
Enrollment
100
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2021
End Date
September 10, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für AnästhesiologieUniversitätsklinikum Heidelberg

Eligibility Criteria

Inclusion Criteria

  • •Patients with aortic valve replacement:
  • •\- Written informed consent by the study participant
  • •\- Age \= 18 years
  • •\- Planned aortic valve replacement in the cardiology or cardiosurgery clinic of Heidelberg University Hospital
  • •Healthy subjects:
  • •\- Written informed consent by the study participant
  • •\- Age \= 18 years

Exclusion Criteria

  • •Exclusion criteria common to all study groups:
  • •\- Failure to meet inclusion criteria.
  • •\- Infectious viral diseases (HBV, HCV, HIV, COVID\-19\) or unknown COVID\-19 status.
  • •\- Refusal to participate in the study
  • •\- Pre\-existing severe renal insufficiency with a glomerular (GFR) \<15 ml/min/m2 or need for dialysis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The effect on the renal functions and blood pressure of DPP-4 Inhibitor for the type 2 diabetic patients .Type 2 diabetes
JPRN-UMIN000005337Kanazawa Medical University Diadetes &amp; Endocrinology100
Not yet recruiting
Not Applicable
Microcirculatory and macrocirculatory alterations in different thyroid statescardiac functionmicrovasculature100822061004373910003216
NL-OMON40419endocrinologie10
Recruiting
Not Applicable
Examination of the effects on renal function and prognosis of various diuretics for liver cirrhosisiver cirrhosis
JPRN-UMIN000040179Hokkaido University400
Recruiting
Not Applicable
Consideration the changes of renal function for renal cell carcinoma patients, administered the molecular target drugs: axitinib, sunitinib and sorafenibRenal cell carcinoma
JPRN-UMIN000019393Dokkyo Medical University, Department of Urology30
Active, not recruiting
Phase 1
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2014-005033-31-FRAddmedica S.A.S